EP 4100125 A1 20221214 - POLYMORPH OF RUCAPARIB MESYLATE
Title (en)
POLYMORPH OF RUCAPARIB MESYLATE
Title (de)
POLYMORPH VON RUCAPARIB-MESYLAT
Title (fr)
POLYMORPHE DE MÉSYLATE DE RUCAPARIB
Publication
Application
Priority
- EP 20155091 A 20200203
- EP 2021052029 W 20210128
Abstract (en)
[origin: WO2021156140A1] The present invention relates to an anhydrous crystalline form of rucaparib mesylate, preferably in polymorphically pure form and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising the anhydrous crystalline form of rucaparib mesylate, preferably in polymorphically pure form and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment of cancer.
IPC 8 full level
A61P 35/00 (2006.01); A61K 31/55 (2006.01); C07D 487/06 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07D 487/06 (2013.01)
Citation (search report)
See references of WO 2021156140A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2021052029 W 20210128; EP 21702480 A 20210128